{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T19:25:04Z","timestamp":1782415504158,"version":"3.54.5"},"reference-count":261,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007343","name":"University of Brescia","doi-asserted-by":"publisher","award":["local funds from University of Brescia, Italy to GT (ex 60% 2018 and 2019)"],"award-info":[{"award-number":["local funds from University of Brescia, Italy to GT (ex 60% 2018 and 2019)"]}],"id":[{"id":"10.13039\/501100007343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Metformin is considered the first-choice drug for type 2 diabetes treatment. Actually, pleiotropic effects of metformin have been recognized, and there is evidence that this drug may have a favorable impact on health beyond its glucose-lowering activity. In summary, despite its long history, metformin is still an attractive research opportunity in the field of endocrine and metabolic diseases, age-related diseases, and cancer. To this end, its mode of action in distinct cell types is still in dispute. The aim of this work was to review the current knowledge and recent findings on the molecular mechanisms underlying the pharmacological effects of metformin in the field of metabolic and endocrine pathologies, including some endocrine tumors. Metformin is believed to act through multiple pathways that can be interconnected or work independently. Moreover, metformin effects on target tissues may be either direct or indirect, which means secondary to the actions on other tissues and consequent alterations at systemic level. Finally, as to the direct actions of metformin at cellular level, the intracellular milieu cooperates to cause differential responses to the drug between distinct cell types, despite the primary molecular targets may be the same within cells. Cellular bioenergetics can be regarded as the primary target of metformin action. Metformin can perturb the cytosolic and mitochondrial NAD\/NADH ratio and the ATP\/AMP ratio within cells, thus affecting enzymatic activities and metabolic and signaling pathways which depend on redox- and energy balance. In this context, the possible link between pyruvate metabolism and metformin actions is extensively discussed.<\/jats:p>","DOI":"10.3390\/ijms222313068","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T21:19:08Z","timestamp":1638479948000},"page":"13068","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area"],"prefix":"10.3390","volume":"22","author":[{"given":"Giovanni","family":"Tulipano","sequence":"first","affiliation":[{"name":"Unit of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s00125-017-4336-x","article-title":"Metformin: Clinical use in type 2 diabetes","volume":"60","author":"Inzucchi","year":"2017","journal-title":"Diabetologia"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Dabrowski, M. (2021). Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041680"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3389\/fendo.2019.00851","article-title":"Editorial: Metformin: Beyond diabetes","volume":"10","author":"Bost","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","article-title":"Metformin as a Tool to Target Aging","volume":"23","author":"Barzilai","year":"2016","journal-title":"Cell Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tem.2017.05.004","article-title":"AMPK as a Therapeutic Target for Treating Metabolic Diseases","volume":"28","author":"Day","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCULATIONAHA.117.031735","article-title":"Reporpusing metformin for cardiovascular disease","volume":"137","author":"Rena","year":"2018","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.tips.2018.07.006","article-title":"Metformin as an anticancer agent","volume":"39","author":"Vancura","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s13679-019-00335-3","article-title":"Metformin: Mechanism in human obesity and weight loss","volume":"8","author":"Yerevanian","year":"2019","journal-title":"Curr. Obes. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Onken, B., and Driscoll, M. (2010). Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans healthspan via AMPK, LKB1, and SKN-1. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0008758"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature11861","article-title":"mTOR is a key modulator of ageing and age-related disease","volume":"493","author":"Johnson","year":"2013","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.cell.2016.11.055","article-title":"An ancient, unified mechanism for metformin growth inhibition in C. elegans and cancer","volume":"167","author":"Wu","year":"2016","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fendo.2018.00372","article-title":"Metabolic profiles associated with metformin efficacy in cancer","volume":"9","author":"Andrzejewski","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1530\/JME-19-0083","article-title":"The role of an antidiabetic drug\u2014Metformin\u2014In the treatment of endocrine tumors","volume":"63","author":"Thakur","year":"2019","journal-title":"J. Mol. Endocrinol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/pr.117.015388","article-title":"International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature","volume":"70","author":"Tulipano","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11154-021-09649-x","article-title":"Autophagy in normal pituitary and pituitary tumor cells and its potential role in the actions of somatostatin receptor ligands in acromegaly","volume":"22","author":"Tulipano","year":"2021","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_16","first-page":"23","article-title":"Metformin blocks obesity associated progression of obesity-activated thyroid cancer in a mouse model","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1756284820927271","DOI":"10.1177\/1756284820927271","article-title":"The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: A review of preclinical to clinical evidence","volume":"13","author":"Pusceddu","year":"2020","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1158\/1078-0432.CCR-17-3167","article-title":"Metformin targets Mitochondrial Glycerophosphate Dehydrogenase (mGPDH) to control Rate of Oxidative Phosphorylation and growth of thyroid cancer in vitro and in vivo","volume":"24","author":"Thakur","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1530\/EC-19-0482","article-title":"How treatments with endocrine and metabolic drugs influence pituitary cell function","volume":"9","author":"Tulipano","year":"2020","journal-title":"Endocr. Connect."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s12020-020-02373-7","article-title":"Differential activity of metformin on reductive activity and energy production in pituitary tumor cells compared to myogenic precursors","volume":"69","author":"Tulipano","year":"2020","journal-title":"Endocrine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10147-021-01895-y","article-title":"The prevalance of secondary neoplasms in acromegalic patients: Possible preventive and\/or protective role of metformin","volume":"26","author":"Costa","year":"2021","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Portari, L.H.C., Correa-Silva, S.R., and Abucham, J. (2021). Prolactin response to metformin in cabergoline-resistant prolactinomas: A pilot study. Neuroendocrinology, Epub ahead of print.","DOI":"10.1159\/000514591"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kaneto, H., Kimura, T., Obata, A., Shimoda, M., and Kaku, K. (2021). Multifaceted mechanisms of action of metformin which have been unraveled one after another in the long history. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052596"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2337\/db16-0032","article-title":"[11C]-labeled metformin distribution in the liver and small intestine using dynamic positron emission tomography in mice demonstrates tissue-specific transporter dependency","volume":"65","author":"Jensen","year":"2016","journal-title":"Diabetes"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.bcp.2005.09.011","article-title":"Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)","volume":"70","author":"Lips","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1124\/dmd.107.015495","article-title":"Metformin transport by a newly cloned proton stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine","volume":"35","author":"Zhou","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.clpt.6100275","article-title":"Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics","volume":"83","author":"Shu","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"27055","DOI":"10.1074\/jbc.M114.570564","article-title":"Taste of a pill: Organic cation transporter-3 (OCT3) mediates metformin accumulation and secretion in salivary glands","volume":"289","author":"Lee","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2967\/jnumed.116.177774","article-title":"In Vivo Imaging of Human 11C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses","volume":"57","author":"Gormsen","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s40262-020-00896-w","article-title":"A comprehensive whole-body physiologically based pharmacokinetic drug-drug-gene interaction model of metformin and cimetidine in healthy adults and renally impaired individuals","volume":"59","author":"Hanke","year":"2020","journal-title":"Clin. Pharmacokinet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2125.1981.tb01206.x","article-title":"Metformin kinetics in healthy subjects and in patients with diabetes mellitus","volume":"12","author":"Tucker","year":"1981","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/00498259409043220","article-title":"Accumulation of metformin by tissues of the normal and diabetic mouse","volume":"24","author":"Wilcock","year":"1994","journal-title":"Xenobiotica"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"dgaa332","DOI":"10.1210\/clinem\/dgaa332","article-title":"Metformin Biodistribution: A Key to Mechanisms of Action?","volume":"105","author":"Sundelin","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and molecular mechanism of metformin action","volume":"42","author":"LaMoia","year":"2021","journal-title":"Endocr. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1210\/jc.2019-00056","article-title":"Biguanides exert antitumoral actions in pituitary tumor cells through AMPK-dependent and \u2013independent mechanisms","volume":"104","author":"Dios","year":"2019","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: Historical overview","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin-mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Agius, L., Ford, B.E., and Cachra, S.S. (2020). The metformin mechanism on gluconeogenesis and AMPK activation: The metabolic perspective. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093240"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00125-016-3992-6","article-title":"Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: Results from two randomised trials","volume":"59","author":"DeFronzo","year":"2016","journal-title":"Diabetologia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","article-title":"Metformin and the gastrointestinal tract","volume":"59","author":"McCreight","year":"2016","journal-title":"Diabetologia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: Systematic review and metanalysis","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and Implications","volume":"33","author":"Dunaif","year":"2012","journal-title":"Endocr. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmv025","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: Systematic review and meta-analysis","volume":"21","author":"Naderpoor","year":"2015","journal-title":"Hum. Reprod. Update"},{"key":"ref_45","first-page":"7624932","article-title":"Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology","volume":"2018","author":"Dadachanji","year":"2018","journal-title":"Genet. Res. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12958-020-00613-z","article-title":"Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway","volume":"18","author":"Zhang","year":"2020","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Shpakov, A.O. (2021). Improvement Effect of Metformin on Female and Male Reproduction in Endocrine Pathologies and Its Mechanisms. Pharmaceuticals, 14.","DOI":"10.3390\/ph14010042"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/EJE-09-0733","article-title":"Metformin: An old medication of new fashion: Evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome","volume":"162","author":"Christakou","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: An overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1210\/clinem\/dgaa605","article-title":"Sustained maternal hyperandrogenism during PCOS pregnancy reduced by metformin in non-obese women carrying a male fetus","volume":"105","author":"Andrae","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/humupd\/dmab004","article-title":"Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome","volume":"27","author":"Rodgers","year":"2021","journal-title":"Hum. Reprod. Update"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.coph.2021.06.002","article-title":"Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers","volume":"60","author":"Gahete","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/14737175.2021.1847645","article-title":"Metformin as a potential therapeutic for neurological disease: Mobilizing AMPK to repair the nervous system","volume":"21","author":"Kothari","year":"2021","journal-title":"Expert Rev. Neurother."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"18591","DOI":"10.1073\/pnas.2005748117","article-title":"Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS\/FTD mice","volume":"117","author":"Zu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Hervas, D., Fornes-Ferrer, V., Gomez-Escribano, A.P., Sequedo, M.D., Peir\u00f3, C., Mill\u00e1n, J.M., and V\u00e1zquez-Manrique, R.P. (2017). Metformin intake associates with better cognitive function in patients with Huntington\u2019s disease. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179283"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/a-1351-0566","article-title":"Metformin Attenuates the Metabolic Disturbance and Depression-like Behaviors Induced by Corticosterone and Mediates the Glucose Metabolism Pathway","volume":"54","author":"Hao","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"UK Prospective Study (UKPDS) Group (1998). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 352, 854\u2013865.","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.coph.2020.10.018","article-title":"Metformin: Still the sweet spot for CV protection in diabetes?","volume":"54","author":"Rena","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cmet.2015.01.003","article-title":"Metformin action: Concentrations matter","volume":"21","author":"He","year":"2015","journal-title":"Cell Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3389\/fendo.2018.00753","article-title":"Metformin induced mitochondrial complex I inhibition: Facts, uncertainties, and consequences","volume":"9","author":"Fontaine","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dci15-0013","article-title":"Mechanism of Metformin: A Tale of Two Sites","volume":"39","author":"Song","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2049-3002-2-12","article-title":"Metformin directly acts on mitochondria to alter cellular bioenergetics","volume":"2","author":"Andrzejewski","year":"2014","journal-title":"Cancer Metab."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20140620","article-title":"Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria","volume":"462","author":"Bridges","year":"2014","journal-title":"Biochem. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e02242","DOI":"10.7554\/eLife.02242","article-title":"Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis","volume":"3","author":"Wheaton","year":"2014","journal-title":"eLife"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.redox.2017.08.018","article-title":"Metformin selectively targets redox control of complex I energy transduction","volume":"14","author":"Cameron","year":"2018","journal-title":"Redox Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41422-019-0163-6","article-title":"Hierarchical activation of compartmentalized pools of AMPK depends on severity of nutrient or energy stress","volume":"29","author":"Zong","year":"2019","journal-title":"Cell Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature23275","article-title":"Fructose-1, 6-bisphosphate and aldolase mediate glucose sensing by AMPK","volume":"548","author":"Zhang","year":"2017","journal-title":"Nature"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1074\/jbc.RA118.006670","article-title":"Low metformin causes a more oxidized mitochondrial NADH\/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism","volume":"294","author":"Alshawi","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"20369","DOI":"10.1074\/jbc.M113.482646","article-title":"Metformin increases mitochondrial energy formation in L6 muscle cell cultures","volume":"288","author":"Vytla","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bbrc.2010.01.119","article-title":"Metformin induces suppression of NAD(P)H oxidase activity in podocytes","volume":"393","author":"Piwkowska","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"114687","DOI":"10.1016\/j.bcp.2021.114687","article-title":"Beneficial effects of metformin on glomerular podocytes in diabetes","volume":"192","author":"Rogacka","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/s41591-018-0125-4","article-title":"Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo","volume":"24","author":"Madiraju","year":"2018","journal-title":"Nat. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1074\/jbc.M114.567271","article-title":"Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK)","volume":"289","author":"Cao","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.celrep.2017.03.011","article-title":"Liver-Specific Activation of AMPK Prevents Steatosis on a High-Fructose Diet","volume":"18","author":"Woods","year":"2017","journal-title":"Cell Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.fct.2018.11.019","article-title":"Differential effects of metformin glycinate and hydrochloride in glucose production, AMPK phosphorylation and insulin sensitivity in hepatocytes from non-diabetic and diabetic mice","volume":"123","author":"Rada","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"10856","DOI":"10.1038\/ncomms10856","article-title":"AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B","volume":"7","author":"Johanns","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2009.03.016","article-title":"Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein","volume":"137","author":"He","year":"2009","journal-title":"Cell"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1172\/JCI40671","article-title":"Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/ AMPK pathway via a decrease in hepatic energy state","volume":"120","author":"Foretz","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.celrep.2016.04.024","article-title":"Hyperglucagonemia mitigates the effect of metformin on glucose production in prediabetes","volume":"15","author":"Konopka","year":"2016","journal-title":"Cell Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e4561","DOI":"10.1002\/nbm.4561","article-title":"Offset of apparent hyperpolarized 13 C lactate flux by the use of adjuvant metformin in ionizing radiation therapy in vivo","volume":"3","author":"Choi","year":"2021","journal-title":"NMR Biomed."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1042\/bj1030514","article-title":"The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver","volume":"103","author":"Williamson","year":"1967","journal-title":"Biochem. J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1074\/jbc.275.1.223","article-title":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I","volume":"275","author":"Nogueira","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2337\/db20-1143","article-title":"Metformin\u2019s Therapeutic Efficacy in the Treatment of Diabetes Does Not Involve Inhibition of Mitochondrial Glycerol Phosphate Dehydrogenase","volume":"70","author":"MacDonald","year":"2021","journal-title":"Diabetes"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1042\/bj2180165","article-title":"Role of fructose 2, 6-bisphosphate in the control by glucagon of gluconeogenesis from various precursors in isolated rat hepatocytes","volume":"218","author":"Hue","year":"1984","journal-title":"Biochem. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fphar.2018.00141","article-title":"Lactate-induced glucose output is unchanged by metformin at a therapeutic concentration\u2014A mass spectrometry imaging study of the perfused rat liver","volume":"9","author":"Calza","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41591-018-0159-7","article-title":"Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase","volume":"24","author":"Hunter","year":"2018","journal-title":"Nat. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1074\/jbc.RA120.012533","article-title":"Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation","volume":"295","author":"Moonira","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/dom.12910","article-title":"Opposite effects of a glucokinase activator and metformin on glucose regulated gene expression in hepatocytes","volume":"19","author":"Fountana","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"108025","DOI":"10.1016\/j.diabres.2020.108025","article-title":"Metformin: An old drug against old age and associated morbidities","volume":"160","author":"Salvatore","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.cmet.2017.04.010","article-title":"Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice","volume":"25","author":"Cokorinos","year":"2017","journal-title":"Cell Metab."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/jcb.29327","article-title":"Effect of metformin on myotube BCAA catabolism","volume":"121","author":"Rivera","year":"2020","journal-title":"J. Cell Biochem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.tips.2020.09.001","article-title":"Metformin and Systemic Metabolism","volume":"41","author":"He","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/dom.14262","article-title":"Dose-dependent accumulation of glucose in the intestinal wall and lumen induced by metformin as revealed by [18F]-labelled fluorodeoxyglucose positron emission tomography-MRI","volume":"23","author":"Ito","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2337\/dc15-0488","article-title":"The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results from Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies","volume":"39","author":"Buse","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00259-007-0563-6","article-title":"High and typical 18F-FDG bowel uptake in patients treated with metformin","volume":"35","author":"Gontier","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1476-5381.1992.tb09093.x","article-title":"Effect of metformin on glucose metabolism in the splanchnic bed","volume":"105","author":"Bailey","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","article-title":"Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism","volume":"7","author":"Morrison","year":"2016","journal-title":"Gut Microbes"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"14405","DOI":"10.1038\/srep14405","article-title":"Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"109131","DOI":"10.1016\/j.biopha.2019.109131","article-title":"Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db\/db mice","volume":"118","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/dme.13040","article-title":"Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes","volume":"33","author":"Dujic","year":"2016","journal-title":"Diabet. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.2337\/dc20-0093","article-title":"Enhanced Release of Glucose into the Intraluminal Space of the Intestine Associated with Metformin Treatment as Revealed by [18F] Fluorodeoxyglucose PET-MRI","volume":"43","author":"Morita","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1210\/en.2006-1237","article-title":"Metformin inhibits adenosine 5\u2032-monophosphate-activated kinase activation and prevents increases in neuropeptide Y expression in cultured hypothalamic neurons","volume":"148","author":"Gamba","year":"2007","journal-title":"Endocrinology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e12996","DOI":"10.1111\/eci.12996","article-title":"Hypothalamic AMPK and energy balance","volume":"48","author":"Lopez","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI68815","article-title":"Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk","volume":"124","author":"Lien","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molmet.2018.03.007","article-title":"Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas","volume":"11","author":"Kuhre","year":"2018","journal-title":"Mol. Metab."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","article-title":"GDF15 mediates the effects of metformin on body weight and energy balance","volume":"578","author":"Coll","year":"2020","journal-title":"Nature"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s42255-019-0146-4","article-title":"Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss","volume":"1","author":"Day","year":"2019","journal-title":"Nat. Metab."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/dom.13519","article-title":"Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case\u2013control study","volume":"21","author":"Natali","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Napolitano, A., Miller, S., Nicholls, A.W., Baker, D., Van Horn, S., Thomas, E., Rajpal, D., Spivak, A., Brown, J.R., and Nunez, D.J. (2014). Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100778"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1038\/s41598-021-81349-7","article-title":"Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells","volume":"11","author":"Yang","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e2106868118","DOI":"10.1073\/pnas.2106868118","article-title":"Activation of the hypothalamic\u2013pituitary\u2013adrenal axis by exogenous and endogenous GDF15","volume":"118","author":"Cimino","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Salvatore, T., Pafundi, P.C., Galiero, R., Rinaldi, L., Caturano, A., Vetrano, E., Aprea, C., Albanese, G., Di Martino, A., and Ricozzi, C. (2021). Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?. Biomedicines, 9.","DOI":"10.3390\/biomedicines9010003"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12958-021-00765-6","article-title":"Metformin reduces androgen receptor and upregulates homeobox A10 expression in uterine endometrium in women with polycystic ovary syndrome","volume":"19","author":"Ohara","year":"2021","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1007\/s00125-017-4335-y","article-title":"The pharmacogenetics of metformin","volume":"60","author":"Floretz","year":"2017","journal-title":"Diabetologia"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1172\/JCI30558","article-title":"Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action","volume":"117","author":"Shu","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng.735","article-title":"Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes","volume":"43","author":"Zhou","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.3632","article-title":"Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Luizon, M.R., Eckalbar, W.L., Wang, Y., Jones, S.C., Smith, R.P., Laurance, M., Lin, L., Gallins, P.J., Etheridge, A.S., and Wright, F. (2016). Genomic characterization of metformin hepatic response. PLoS Genet., 12.","DOI":"10.1371\/journal.pgen.1006449"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"eaaz1803","DOI":"10.1126\/scitranslmed.aaz1803","article-title":"Epigenetic markers associated with metformin response and intolerance in drug-na\u00efve patients with type 2 diabetes","volume":"12","author":"Perfilyev","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13148-018-0593-x","article-title":"Significantly altered peripheral blood cell DNA methylation profile as a result of immediate effect of metformin use in healthy individuals","volume":"10","author":"Elbere","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ab.2009.03.040","article-title":"Monitoring phosphorylation of the pyruvate dehydrogenase complex","volume":"389","author":"Rardin","year":"2009","journal-title":"Anal. Biochem."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4093\/dmj.2015.39.3.188","article-title":"Pyruvate dehydrogenase kinases: Therapeutic targets for diabetes and cancers","volume":"39","author":"Jeoung","year":"2015","journal-title":"Diabetes Metab. J."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.bbamcr.2016.01.017","article-title":"The mitochondrial pyruvate carrier in health and disease: To carry or not to carry?","volume":"1863","author":"Bender","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mce.2017.02.014","article-title":"The complex roles of STAT3 and STAT5 in maintaining redox balance: Lessons from STATmediated xCT expression in cancer cells","volume":"451","author":"Singh","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"djx071","DOI":"10.1093\/jnci\/djx071","article-title":"Therapeutic Targeting of the Pyruvate Dehydrogenase Complex\/Pyruvate Dehydrogenase Kinase (PDC\/PDK) Axis in Cancer","volume":"109","author":"Stacpoole","year":"2017","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1474-9726.2012.00805.x","article-title":"The pyruvate dehydrogenase complex as a therapeutic target for age-related diseases","volume":"11","author":"Stacpoole","year":"2012","journal-title":"Aging Cell"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ymgme.2011.09.032","article-title":"The spectrum of pyruvate dehydrogenase complex deficiency: Clinical, biochemical and genetic features in 371 patients","volume":"105","author":"Patel","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ymgme.2006.04.015","article-title":"Magnetic resonance spectroscopic investigation of mitochondrial fuel metabolism and energetics in cultured human fibroblasts: Effects of pyruvate dehydrogenase complex deficiency and dichloroacetate","volume":"89","author":"Simpson","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ccr.2007.07.006","article-title":"HIF and c-Myc: Sibling rivals for control of cancer cell metabolism and proliferation","volume":"12","author":"Gordan","year":"2007","journal-title":"Cancer Cell"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2010.08.006","article-title":"Hypoxia-inducible factor 1: Regulator of mitochondrial metabolism and mediator of ischemic preconditioning","volume":"1813","author":"Semenza","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"23111","DOI":"10.1074\/jbc.M202487200","article-title":"Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis","volume":"277","author":"Lu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"41928","DOI":"10.1074\/jbc.M508718200","article-title":"Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1","volume":"280","author":"Lu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1074\/jbc.M511397200","article-title":"The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism","volume":"281","author":"Ullah","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.1073\/pnas.1106123108","article-title":"CD147 subunit of lactate \u2044 H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors","volume":"108","author":"Chiche","year":"2011","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ccr.2006.10.020","article-title":"A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth","volume":"11","author":"Bonnet","year":"2007","journal-title":"Cancer Cell"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"H570","DOI":"10.1152\/ajpheart.01324.2007","article-title":"Mitochondrial metabolism, redox signaling, and fusion: A mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer","volume":"294","author":"Archer","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.cell.2014.11.046","article-title":"Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity","volume":"159","author":"Mathias","year":"2014","journal-title":"Cell"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1158\/0008-5472.CAN-14-3745","article-title":"Amino acid transporters in cancer and their relevance to \u201cglutamine addiction\u201d: Novel targets for the design of a new class of anticancer drugs","volume":"75","author":"Bhutia","year":"2015","journal-title":"Cancer Res."},{"key":"ref_143","first-page":"617","article-title":"Dichloroacetate and cancer: New home for an orphan drug?","volume":"1846","author":"Kankotia","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.tibs.2010.07.003","article-title":"Sirtuin regulation of mitochondria: Energy production, apoptosis, and signaling","volume":"35","author":"Verdin","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.canlet.2014.01.015","article-title":"Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells","volume":"346","author":"Choi","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/ncomms3192","article-title":"Metformin improves healthspan and lifespan in mice","volume":"4","author":"Mercken","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Palma, F.R., Ratti, B.A., Paviani, V., Coelho, D.R., Miguel, R., Danes, J.M., Zaichik, S.V., de Abreu, A.L., Silva, S.O., and Chen, Y. (2021). AMPK-deficiency forces metformin-challenged cancer cells to switch from carbohydrate metabolism to ketogenesis to support energy metabolism. Oncogene, Epub ahead of print.","DOI":"10.1038\/s41388-021-01943-x"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"32844","DOI":"10.1074\/jbc.M706127200","article-title":"Overexpression of the Cytosolic Form of Phosphoenolpyruvate Carboxykinase (GTP) in Skeletal Muscle Repatterns Energy Metabolism in the Mouse","volume":"282","author":"Hakimi","year":"2007","journal-title":"J. Biol Chem."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e12723","DOI":"10.1111\/acel.12723","article-title":"Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults","volume":"17","author":"Kulkarni","year":"2018","journal-title":"Aging Cell."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0885-4505(86)90081-2","article-title":"Regulation of muscle pyruvate metabolism during exercise","volume":"35","author":"Dohm","year":"1986","journal-title":"Biochem. Med. Metab. Biol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"C834","DOI":"10.1152\/ajpcell.1990.259.5.C834","article-title":"Tricarboxylic acid cycle intermediates in human muscle during prolonged exercise","volume":"259","author":"Sahlin","year":"1990","journal-title":"Am. J. Physiol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1469-7793.1997.703bj.x","article-title":"Anaplerotic processes in human skeletal muscle during brief dynamic exercise","volume":"502","author":"Gibala","year":"1997","journal-title":"J. Physiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-2275(20)36732-8","article-title":"Development of brown and white adipose tissue","volume":"16","author":"Hahn","year":"1975","journal-title":"J. Lipid Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"C1870","DOI":"10.1152\/ajpcell.2000.279.6.C1870","article-title":"Guanine nucleotide transport by atractyloside-sensitive and -insensitive carriers in isolated heart mitochondria","volume":"279","author":"McKee","year":"2000","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"G572","DOI":"10.1152\/ajpgi.00484.2011","article-title":"Relative contribution of THTR-1 and THTR-2 in thiamin uptake by pancreatic acinar cells: Studies utilizing Slc19a2 and Slc19a3 knockout mouse models","volume":"302","author":"Subramanian","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2012.02.028","article-title":"Thiamine is a substrate of organic cation transporters in Caco-2 cells","volume":"682","author":"Lemos","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"9983","DOI":"10.1073\/pnas.1314939111","article-title":"OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin","volume":"111","author":"Chen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1124\/dmd.120.000170","article-title":"Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations","volume":"48","author":"Meyer","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/ajcn\/nqz255","article-title":"Drug-nutrient interactions: Discovering prescription drug inhibitors of the thiamine transporter ThTR-2 (SLC19A3)","volume":"111","author":"Vora","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/0008-5472.CAN-13-0080","article-title":"Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism","volume":"73","author":"Fendt","year":"2013","journal-title":"Cancer Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1038\/onc.2012.529","article-title":"The PGC-1\/ERR signaling axis in cancer","volume":"32","author":"Deblois","year":"2013","journal-title":"Oncogene"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"15063","DOI":"10.1038\/cddiscovery.2015.63","article-title":"AMPK maintains energy homeostasis and survival in cancer cells via regulating p38\/PGC-1alpha-mediated mitochondrial biogenesis","volume":"1","author":"Chaube","year":"2015","journal-title":"Cell Death Discov."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1158\/0008-5472.CAN-11-2967","article-title":"PGC-1alpha promotes the growth of ErbB2\/Neu-induced mammary tumors by regulating nutrient supply","volume":"72","author":"Klimcakova","year":"2012","journal-title":"Cancer Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2049-3002-1-22","article-title":"PGC-1alpha supports glutamine metabolism in breast cancer","volume":"1","author":"McGuirk","year":"2013","journal-title":"Cancer Metab."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cmet.2017.09.006","article-title":"PGC-1a promotes breast cancer metastasis and confers bioenergetic flexibility against metabolic drugs","volume":"26","author":"Andrzejewski","year":"2017","journal-title":"Cell Metab."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MOL.0b013e328328d0a4","article-title":"PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure","volume":"20","author":"Canto","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mce.2016.09.002","article-title":"The metabolic sensor Sirt1 and the hypothalamus: Inteplay between peptide hormones and pro-hormone covertases","volume":"438","author":"Nillni","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity","volume":"458","author":"Canto","year":"2009","journal-title":"Nature"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.mce.2012.10.017","article-title":"Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells","volume":"365","author":"Tulipano","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"37538","DOI":"10.18632\/oncotarget.16556","article-title":"Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells","volume":"8","author":"An","year":"2017","journal-title":"Oncotarget"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mce.2017.09.030","article-title":"Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals","volume":"470","author":"Faggi","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1111\/jcmm.13963","article-title":"Metformin inhibits growth and prolactin secretion of pituitary prolactinoma cells and xenografts","volume":"22","author":"Gao","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2018.07.007","article-title":"Metformin suppresses growth and adrenocorticotrophic hormone secretion in mouse pituitary corticotroph tumor AtT20 cells","volume":"478","author":"Jin","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0197-0186(01)00097-3","article-title":"Substratedependence of reduction of MTT: A tetrazolium dye differs in cultured astroglia and neurons","volume":"40","author":"Takahashi","year":"2002","journal-title":"Neurochem. Int."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"108124","DOI":"10.1016\/j.abb.2019.108124","article-title":"Differential contribution of pyruvate carboxylation to anaplerosis and cataplerosis during non-gluconeogenic and gluconeogenic conditions in HepG2 cells","volume":"676","author":"Wattanavanitchakorn","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2220\/biomedres.34.221","article-title":"Impact of 2-deoxy-D-glucose on the target metabolome profile of a human endometrial cancer cell line","volume":"34","author":"Urakami","year":"2013","journal-title":"Biomed. Res."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-09-2782","article-title":"Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells","volume":"70","author":"Laurent","year":"2010","journal-title":"Cancer Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ccell.2019.03.007","article-title":"Combination of hypoglycemia and metformin impairs tumor metabolic plasticity and growth by modulating the PP2A-GSK3b- MCL-1 axis","volume":"35","author":"Elgendy","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"105749","DOI":"10.1073\/pnas.1409844111","article-title":"Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stemcells","volume":"111","author":"Janzer","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Machado, I.F., Teodoro, J.S., Castela, A.C., Palmeira, C.M., and Rolo, A.P. (2021). miR-378a-3p Participates in Metformin\u2019s Mechanism of Action on C2C12 Cells under Hyperglycemia. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020541"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ebiom.2016.01.035","article-title":"MiR-378 activates the pyruvate-PEP futile cycle and enhances lipolysis to ameliorate obesity in mice","volume":"5","author":"Zhang","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"55057","DOI":"10.18632\/oncotarget.10842","article-title":"Metformin increases PDH and suppresses HIF-1\u03b1 under hypoxic conditions and induces cell death in oral squamous cell carcinoma","volume":"34","author":"Guimaraes","year":"2016","journal-title":"Oncotarget"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40170-018-0193-4","article-title":"The novel function of tumor protein D54 in regulating pyruvate dehydrogenase and metformin cytotoxicity in breast cancer","volume":"7","author":"Zhuang","year":"2019","journal-title":"Cancer Metab."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tips.2012.11.005","article-title":"Metformin and cancer: From the old medicine cabinet to pharmacological pitfalls and prospects","volume":"34","author":"Riedmaier","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.arr.2017.08.003","article-title":"Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis","volume":"40","author":"Campbell","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fonc.2019.00902","article-title":"Impact of metformin on systemic metabolism of patients with advanced pancreatic neuroendocrine tumors","volume":"9","author":"Vernieri","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Zahra, M.H., Afify, S.M., Hassan, G., Nawara, H.M., Kumon, K., Seno, A., and Seno, M. (2021). Metformin suppresses self-renewal and stemness of cancer stem cell models derived from pluripotent stem cells. Cell Biochem. Funct., Online ahead of print.","DOI":"10.1002\/cbf.3661"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: A consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12967-021-02860-z","article-title":"Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts","volume":"19","author":"Moon","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/acel.12338","article-title":"Interventions to slow aging in humans: Are we ready?","volume":"14","author":"Longo","year":"2015","journal-title":"Aging Cell"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/acel.12329","article-title":"Long-lived Snell dwarf mice display increased proteostatic mechanisms that are not dependent on decreased mTORC1 activity","volume":"14","author":"Drake","year":"2015","journal-title":"Aging Cell"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/gerona\/glz058","article-title":"Differential effects of rapamycin and metformin in combination with rapamycin on mechanisms of proteostasis in cultured skeletal myotubes","volume":"75","author":"Wolff","year":"2020","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2020.04.015","article-title":"Metformin enhances autophagy and normalizes mitochondrial function to alleviate aging-associated inflammation","volume":"32","author":"Bharath","year":"2020","journal-title":"Cell Metab."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"115523","DOI":"10.1016\/j.taap.2021.115523","article-title":"Metformin leads to accumulation of reactive oxygen species by inhibiting the NFE2L1 expression in human hepatocellular carcinoma cells","volume":"420","author":"Gou","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"14002","DOI":"10.1038\/s41598-021-93270-0","article-title":"Metformin-induced ROS upregulation as amplified by apigenin causes profound anticancer activity while sparing normal cells","volume":"11","author":"Warkad","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1113\/jphysiol.2006.108324","article-title":"AMPK and cell proliferation\u2014AMPK as a therapeutic target for atherosclerosis and cancer","volume":"574","author":"Motoshima","year":"2006","journal-title":"J. Physiol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.RES.0000256090.42690.05","article-title":"AMP-activated protein kinase in metabolic control and insulin signaling","volume":"100","author":"Towler","year":"2007","journal-title":"Circ. Res."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"20170774","DOI":"10.1098\/rsif.2017.0774","article-title":"Keeping the home fires burning: AMP-activated protein kinase","volume":"15","author":"Hardie","year":"2018","journal-title":"J. R. Soc. Interface"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: Guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1096\/fj.201700442R","article-title":"AMPK in skeletal muscle function and metabolism","volume":"32","author":"Kjobsted","year":"2018","journal-title":"FASEB J."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4161\/cc.11.2.18813","article-title":"Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers","volume":"11","author":"Deng","year":"2012","journal-title":"Cell Cycle"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"890","DOI":"10.18632\/aging.100239","article-title":"STAT3, HIF-1, glucose addiction and Warburg effect","volume":"2","author":"Darnell","year":"2010","journal-title":"Aging"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Cioce, M., Pulito, C., Strano, S., Blandino, G., and Fazio, V.M. (2020). Metformin: Metabolic rewiring faces tumor heterogeneity. Cells, 9.","DOI":"10.3390\/cells9112439"},{"key":"ref_205","first-page":"31","article-title":"Metformin inhibits epithelial-mesenchymal transition of oral squamous cell carcinoma via the mTOR\/HIF-1\u03b1\/PKM2\/STAT3 pathway","volume":"21","author":"Yin","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/s41388-021-01682-z","article-title":"Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2\/STAT3\/SOX2 signaling","volume":"40","author":"Wang","year":"2021","journal-title":"Oncogene"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.tem.2019.07.009","article-title":"The FoxO-Autophagy Axis in Health and Disease","volume":"30","author":"Cheng","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1080\/15548627.2016.1214780","article-title":"Epigenetic and transcriptional regulation of autophagy","volume":"12","author":"Shin","year":"2016","journal-title":"Autophagy"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00018-015-2112-y","article-title":"FOXO transcription factors in cancer development and therapy","volume":"73","author":"Demoulin","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2013.11.049","article-title":"Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome","volume":"156","author":"Menon","year":"2014","journal-title":"Cell"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1158\/0008-5472.CAN-07-2310","article-title":"Metformin inhibits mammalian target of rapamycin-dependent translation in breast cancer cells","volume":"67","author":"Dowling","year":"2007","journal-title":"Cancer Res."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","article-title":"Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner","volume":"11","author":"Kalender","year":"2010","journal-title":"Cell Metab."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.celrep.2020.01.024","article-title":"Phenformin inhibits Hedgehog-dependent tumor growth through a Complex I-independent redox\/corepressor module","volume":"30","author":"Manni","year":"2020","journal-title":"Cell Rep."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Gonnissen, A., Isebaert, S., McKee, C.M., Muschel, R.J., and Haustermans, K. (2017). The effect of metformin and GANT61 combinations on the radiosensitivity of prostate cancer cells. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020399"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3892\/ijmm.2015.2217","article-title":"Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer","volume":"36","author":"Fan","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3892\/mmr.2017.6205","article-title":"Metformin suppresses the expression of Sonic hedgehog in gastric cancer cells","volume":"15","author":"Song","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_218","first-page":"1765","article-title":"Metformin suppresses Sonic Hedgehog expression in pancreatic cancer cells","volume":"34","author":"Nakamura","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaad.2021.02.042","article-title":"Metformin is associated with decreased risk of basal cell carcinoma: A whole-population case-control study from Iceland","volume":"85","author":"Adalsteinsson","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_220","first-page":"4265","article-title":"Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells","volume":"7","author":"Ciaramella","year":"2015","journal-title":"Oncotarget"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1517\/13543784.2013.828691","article-title":"Metformin in lung cancer: Rationale for a combination therapy","volume":"22","author":"Morgillo","year":"2013","journal-title":"Rev. Expert Opin. Investig. Drugs"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"e000132","DOI":"10.1136\/esmoopen-2016-000132","article-title":"Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: A multicentre, open-label phase I\u2013II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer","volume":"2","author":"Morgillo","year":"2017","journal-title":"ESMO Open"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/15548627.2019.1569913","article-title":"Metformin alleviates hyperglycemia-induced endothelial impairment by downregulating autophagy via the Hedgehog pathway","volume":"15","author":"Niu","year":"2019","journal-title":"Autophagy"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"25154","DOI":"10.1074\/jbc.M116.742247","article-title":"Activation of AMP-activated protein kinase by metformin induces protein acetylation in prostate and ovarian cancer cells","volume":"291","author":"Galdieri","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"39939","DOI":"10.18632\/oncotarget.17829","article-title":"Metformin induces protein acetylation in cancer cells","volume":"8","author":"Vancura","year":"2017","journal-title":"Oncotarget"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"e12772","DOI":"10.1111\/acel.12772","article-title":"Metformin directly targets the H3K27me3 demethylase KDM6A\/UTX","volume":"17","author":"Cuyas","year":"2018","journal-title":"Aging Cell"},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Spada, A., Mantovani, G., Lania, A.G., Treppiedi, D., Mangili, F., Catalano, R., Carosi, G., Sala, E., and Peverelli, E. (2021). Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior. Neuroendocrinology, Epub ahead of print.","DOI":"10.1159\/000514862"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"C5","DOI":"10.1530\/ERC-17-0004","article-title":"From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): An International Pituitary Pathology Club proposal","volume":"24","author":"Asa","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Giustina, A. (2021). Pituitary adenoma\u2026nomen omen?. Endocrine, Epub ahead of print.","DOI":"10.1007\/s12020-021-02785-z"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1172\/JCI39375","article-title":"Acromegaly pathogenesis and treatment","volume":"119","author":"Melmed","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.mce.2013.12.006","article-title":"Cyclic adenosine 30-50-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac)","volume":"383","author":"Vitali","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.wneu.2018.02.188","article-title":"Combination treatment with bromocriptine and metformin in patients with bromocriptine-resistant prolactinomas: Pilot study","volume":"115","author":"Liu","year":"2018","journal-title":"World Neurosurg."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Krysiak, R., Kowalcze, K., and Okopie\u0144, B. (2021). Vitamin D status determines the impact of metformin on circulating prolactin levels in premenopausal women. J. Clin. Pharm. Ther, Epub ahead of print.","DOI":"10.1111\/jcpt.13447"},{"key":"ref_234","first-page":"20","article-title":"Acromegaly","volume":"5","author":"Colao","year":"2019","journal-title":"Nat. Rev. Dis."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.tem.2016.04.014","article-title":"Current and emerging aspects of diabetes mellitus in acromegaly","volume":"27","author":"Frara","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"dgz096","DOI":"10.1210\/clinem\/dgz096","article-title":"A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update","volume":"105","author":"Giustina","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1530\/EJE-20-0795","article-title":"Possible protective role of metformin therapy on colonic polyps in acromegaly: An exploratory cross-sectional study","volume":"184","author":"Albertelli","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-062613-093128","article-title":"Metformin in cancer treatment and prevention","volume":"66","author":"Morales","year":"2015","journal-title":"Ann. Rev. Med."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1152\/physrev.00030.2014","article-title":"Obesity and diabetes: The increased risk of cancer and cancer-related mortality","volume":"95","author":"Gallagher","year":"2015","journal-title":"Physiol. Rev."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1267\/ahc.21-00007","article-title":"Metabolic Reprogramming Drives Pituitary Tumor Growth through Epigenetic Regulation of TERT","volume":"5","author":"Onizuka","year":"2021","journal-title":"Acta Histochem. Cytochem."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neo.2017.09.002","article-title":"Nothing But NET: A Review of neuroendocrine Tumors and Carcinomas","volume":"19","author":"Oronsky","year":"2017","journal-title":"Neoplasia"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000375164","article-title":"Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: A systematic review and meta-analysis","volume":"101","author":"Haugvik","year":"2015","journal-title":"Neuroendocrinology"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2217\/fon-2015-0077","article-title":"2016 Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes","volume":"12","author":"Pusceddu","year":"2016","journal-title":"Future Oncol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/j.gastro.2018.04.010","article-title":"Metformin Use Is Associated with Longer Progression-Free Survival of Patients with Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and\/or Somatostatin Analogues","volume":"155","author":"Pusceddu","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/ijc.32042","article-title":"Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)","volume":"144","author":"Vernieri","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_246","first-page":"498","article-title":"Anticancer effects of metformin on neuroendocrine tumor cells in vitro","volume":"13","author":"Vlotides","year":"2014","journal-title":"Hormones"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/jc.2018-01455","article-title":"Type 2 Diabetes in Neuroendocrine Tumors: Are Biguanides and Statins Part of the Solution?","volume":"104","author":"Gahete","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Vitali, E., Boemi, I., Tarantola, G., Piccini, S., Zerbi, A., Veronesi, G., Baldelli, R., Mazziotti, G., Smiroldo, V., and Lavezzi, E. (2020). Metformin and Everolimus: A Promising combination for Neuroendocrine Tumors Treatment. Cancers, 12.","DOI":"10.1530\/endoabs.70.AEP724"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"110803","DOI":"10.1016\/j.mce.2020.110803","article-title":"A novel insight into the anticancer mechanism of metformin in pancreatic neuroendocrine tumor cells","volume":"509","author":"Vitali","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000481887","article-title":"GSK3alpha\/beta: A Novel Therapeutic Target for Neuroendocrine Tumors","volume":"106","author":"Weis","year":"2018","journal-title":"Neuroendocrinology"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1200\/JCO.2008.21.5988","article-title":"Pancreatic endocrine tumors: Expression profiling evidences a role for AKT-mTOR pathway","volume":"28","author":"Missiaglia","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.5754\/hge11212","article-title":"mTOR activation in well differentiated pancreatic neuroendocrine tumors: A retrospective study on 34 cases","volume":"58","author":"Zhou","year":"2011","journal-title":"Hepatogastroenterology"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib malate for the treatment of pancreatic neuroendocrine tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"Rojo","year":"2006","journal-title":"Cancer Res."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1002\/cncr.26011","article-title":"Limitations in small intestinal neuroendocrine tumor therapy by mTOR kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1\/2 and AKT","volume":"117","author":"Svejda","year":"2011","journal-title":"Cancer"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/jne.12231","article-title":"Role of AMP-activated protein kinase (AMPK) activators in antiproliferative multi-drug pituitary tumor therapies: Effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells","volume":"27","author":"Tulipano","year":"2015","journal-title":"J. Neuroendocrinol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/bjc.2016.25","article-title":"Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors","volume":"114","author":"Vandamme","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2796.2004.01328.x","article-title":"The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: A systematic review","volume":"256","author":"Wulffele","year":"2004","journal-title":"J. Intern. Med."},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Lauretta, R., Lanzolla, G., Vici, P., Mariani, L., Moretti, C., and Appetecchia, M. (2016). Insulin-sensitizers, polycystic ovary syndrome and gynaecological cancer risk. Int. J. Endocrinol., 8671762.","DOI":"10.1155\/2016\/8671762"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s42255-019-0032-0","article-title":"Metabolic signatures of cancer cells and stem cells","volume":"1","author":"Intlekofer","year":"2019","journal-title":"Nat. Metab."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/23\/13068\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:39:03Z","timestamp":1760168343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/23\/13068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":261,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["ijms222313068"],"URL":"https:\/\/doi.org\/10.3390\/ijms222313068","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]}}}